Anzemet and Miacalcin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Anzemet (dolasetron mesylate) and Miacalcin (calcitonin, salmon). Common drug interactions include back pain among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Anzemet and Miacalcin. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

What is Miacalcin?

Miacalcin has active ingredients of calcitonin, salmon. It is often used in osteoporosis. eHealthMe is studying from 5,437 Miacalcin users. Check the latest studies of Miacalcin.

On Aug, 10, 2026

12 people who take Anzemet and Miacalcin together, and have interactions are studied.

Anzemet and Miacalcin drug interactions.

What are the common drug interactions of Anzemet and Miacalcin, by gender? *:

female:

Back pain
Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
Constipation
Death
Dizziness
Fatigue (feeling of tiredness)
Gallbladder enlargement
Lymphangiosis carcinomatosa (inflammation of the lymph vessels can lead to cancer)
Malignant neoplasm progression (cancer tumour came back)
Nausea (feeling of having an urge to vomit)

male:

Dizziness
Headache (pain in head)
Biliary dilatation
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Bone marrow oedema (inflammation that causes much than the needed fluid in a bone)
Bone pain
Carcinoid syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction)
Carcinoid tumour of the small bowel
Cellulitis (infection under the skin)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

What are the common drug interactions of Anzemet and Miacalcin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Dyspnoea (difficult or laboured respiration)
Nausea (feeling of having an urge to vomit)
Sensory disturbance (sense disturbance)
Vision blurred
Anxiety
Blood pressure immeasurable
Dizziness

60+:

Dizziness
Abdominal pain
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Bone marrow oedema (inflammation that causes much than the needed fluid in a bone)
Bone pain
Carcinoid syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction)
Carcinoid tumour of the small bowel
Cellulitis (infection under the skin)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Chondromalacia (anterior knee pain due to irritation of the cartilage on the under surface of the kneecap)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Pain: 2 people, 16.67%
Multiple Myeloma (cancer of the plasma cells): 2 people, 16.67%
Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 16.67%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 16.67%
Anaemia (lack of blood): 2 people, 16.67%
Indigestion: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Anzemet and Miacalcin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously